The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications.

The latest trend in treating hair loss may sound familiar -- essentially, it's a repurposed drug first popularized in the ...

Thursday marks 27 years since the U.S. Food and Drug Administration approved the sale of Viagra ... night monologues – its approval by the FDA legitimized sexual health as a concern.

According to GSK, the last time the FDA cleared a new class of antibiotics for uncomplicated UTIs was in 1996, with the approval of fosfomycin. (Last year, the agency approved the drug Pivya for ...

GSK plans to launch the drug in the US in the second half of the year, and did not disclose details on pricing. The FDA approved GSK’s drug for a common type of urinary tract infection in women ...

On Saturday, Eli Lilly And Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) said adolescent patients with severe alopecia ... the U.S. Food and Drug Administration (FDA) approved baricitinib ...

Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler ...

In 2022, the U.S. Food and Drug Administration (FDA) approved baricitinib, also known as Olumiant, for adult patients with severe AA. Price Action: LLY stock is down 0.57% at $825.01, and INCY ...